| PLA17A11 |
Optoacoustic chemical microscopy |
Imaging/Device |
Broadband |
Prototype use and validation |
WO 2019/149744 |
| PLA17A05 |
Risk score for patients to develop (pre)-symptomatic type 1 diabetes |
Biomarker/Algorithm |
Type 1 Diabetes (T1D) |
Product development |
WO 2019/002364 |
| PLA16A08 |
Early biomarkers for the diagnosis of bronchopulmonary dysplasia |
Biomarker |
Bronchopulmonary dysplasia (BPD) |
Product development |
WO 2018/091665 |
| PLA17A08 |
Novel optoacoustic endoscope for diagnostic purposes |
Imaging/Device |
Broadband, Cancer |
Prototype development |
WO 2019/034633 |
| PLA18A11 |
AI-driven procedure for drug response prediction in cancer |
Biomarker/Algorithm |
Cancer |
Validation |
PCT application filed |
| PLA19A19 |
Technology for large tissue labelling, clearing and transparency imaging |
Imaging/Algorithm |
Cancer |
Validation |
WO 2018/224289 |
| PLA13A20 |
Activity-based Probes (ABP) for the detection and monitoring of MALT1-paracaspase activity |
Molecular Probe |
Cancer |
Validation |
WO 2015/110406 |
| PLA15A03 |
Micro RNA signature predicting treatment outcome of glioblastoma patients |
Biomarker |
Cancer |
Validation |
WO 2017/109089 |
| PLA15A21 |
Non-invasive organ-specific exosomal biomarkers for liquid biopsy |
Biomarker |
Diabetes |
Validation |
WO 2017/194499 |
| PLA19A03 |
Method and device for imaging fluorescent proteins in near- and short-wave infrared |
Imaging/Device |
Broadband |
Validation |
Priority-establishing patent application filed |
| PLA19A04 |
System and method for real-time multicolor shortwave infrared fluorescence imaging |
Imaging/Device |
Broadband |
Validation |
Priority-establishing patent application filed |
